论文部分内容阅读
By mimicking high density lipoprotein in the central nervous system(CNS),we constructed discoidal apolipoprotein E3-reconstituted high-density lipoprotein(ApoE3-rHDL)as an efficient nanoplatform that could penetrate the blood-brain barrier(BBB)and accelerate Aβ clearance to serve as a novel nanomedicine for the therapy of AD.